Sidley represented Deep Longevity Inc. in its Series A financing led by ETP Ventures and Human Longevity and Performance Impact Venture Fund (HLPIVF). The investment round includes participation from BOLD Capital Partners, Longevity Vision Fund, Formic Ventures, and LongeVC.
Deep Longevity, spun out of Insilico Medicine, is a leading artificial intelligence (AI) biotech startup company, specializing in using artificial intelligence to develop deep biomarkers of aging and longevity technology.
The deal was led by partner Ruchun Ji. Other team members include China advisor Flora Wu, legal assistant Yixuan Sheng, and paralegal Andrea Panayides.